Comparison of metabolic parameters during treatment for schizophrenia with olanzapine intramuscular long-acting injection versus olanzapine oral formulation

被引:0
|
作者
Gulliver, A. [1 ]
McDonnell, D. P. [1 ]
Kryzhanovskaya, L. A. [1 ]
Zhao, F. [1 ]
Detke, H. C. [1 ]
Feldman, P. D. [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [21] Olanzapine long-acting injection: When and for how long is oral supplementation required?
    Chew, Majella Su-Xian
    Dhillon, Rohan
    Tibrewal, Prashant
    Narang, Birinder
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (12): : 1214 - 1215
  • [22] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [23] Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study
    Detke, H.
    Weiden, P. J.
    Lambert, T.
    Llorca, P. M.
    Choukour, M.
    Watson, S. B.
    Brunner, E.
    Ascher-Svanum, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S464 - S464
  • [24] Olanzapine concentrations collected postmortem in patients treated with olanzapine long-acting injection
    McDonnell, D. P.
    Detke, H. C.
    Falk, M.
    Shatapathy, C. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S489 - S490
  • [25] Olanzapine Long-Acting InjectionA Review of its Use in the Treatment of Schizophrenia
    James E. Frampton
    Drugs, 2010, 70 : 2289 - 2313
  • [26] Long-acting olanzapine injection during pregnancy and breastfeeding: a case report
    Manouilenko, Irina
    Ohman, Inger
    Georgieva, Jeanette
    ARCHIVES OF WOMENS MENTAL HEALTH, 2018, 21 (05) : 587 - 589
  • [27] Long-acting olanzapine injection during pregnancy and breastfeeding: a case report
    Irina Manouilenko
    Inger Öhman
    Jeanette Georgieva
    Archives of Women's Mental Health, 2018, 21 : 587 - 589
  • [28] Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
    Heres, Stephan
    Kraemer, Susanne
    Bergstrom, Richard F.
    Detke, Holland C.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 299 - 312
  • [29] Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
    Katagiri, Hideaki
    Taketsuna, Masanori
    Kondo, Shinpei
    Kajimoto, Kenta
    Aoi, Etsuko
    Tanji, Yuka
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 1083 - 1091
  • [30] OLANZAPINE LONG-ACTING INJECTION FOR SCHIZOPHRENIA: AN EVALUATION OF PATIENT FUNCTIONING DURING 24 WEEKS OF MAINTENANCE THERAPY
    Novick, D.
    Anand, H.
    Ascher-Svanum, H.
    Haro, J.
    Bertsch, J.
    Cui, Z.
    Detke, H.
    Mcdonnell, D.
    Montgomery, W.
    VALUE IN HEALTH, 2011, 14 (07) : A287 - A287